BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 8557506)

  • 21. Contrast-enhanced MR imaging of the breast in patients with breast implants after cancer surgery.
    Boné B; Aspelin P; Isberg B; Perbeck L; Veress B
    Acta Radiol; 1995 Mar; 36(2):111-6. PubMed ID: 7710787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance galactography for a patient with nipple discharge.
    Yoshimoto M; Kasumi F; Iwase T; Takahashi K; Tada T; Uchida Y
    Breast Cancer Res Treat; 1997 Jan; 42(1):87-90. PubMed ID: 9116323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. False-positive results in dynamic MR mammography. Causes, frequency, and methods to avoid.
    Kaiser WA
    Magn Reson Imaging Clin N Am; 1994 Nov; 2(4):539-55. PubMed ID: 7489307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Three-phase dynamic breast magnetic resonance imaging with two-way subtraction.
    Choi N; Han BK; Choe YH; Kim HS
    J Comput Assist Tomogr; 2005; 29(6):834-41. PubMed ID: 16272861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative analysis of multi-slice Gd-DTPA enhanced dynamic MR images using an automated simplex minimization procedure.
    Buckley DL; Kerslake RW; Blackband SJ; Horsman A
    Magn Reson Med; 1994 Nov; 32(5):646-51. PubMed ID: 7808266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ductal carcinoma in situ: is there a role for MRI?
    Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of MR mammography in the detection and exclusion of recurrent breast carcinoma.
    Rieber A; Merkle E; Zeitler H; Görich J; Kreienberg R; Brambs HJ; Tomczak R
    J Comput Assist Tomogr; 1997; 21(5):780-4. PubMed ID: 9294575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Observer variability in the interpretation of contrast enhanced MRI of the breast.
    Mussurakis S; Buckley DL; Coady AM; Turnbull LW; Horsman A
    Br J Radiol; 1996 Nov; 69(827):1009-16. PubMed ID: 8958017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
    Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
    Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast disease: tissue characterization with Gd-DTPA enhancement profiles.
    Stack JP; Redmond OM; Codd MB; Dervan PA; Ennis JT
    Radiology; 1990 Feb; 174(2):491-4. PubMed ID: 2296657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model.
    Tofts PS; Berkowitz B; Schnall MD
    Magn Reson Med; 1995 Apr; 33(4):564-8. PubMed ID: 7776889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage.
    Stomper PC; Herman S; Klippenstein DL; Winston JS; Budnick RM; Stewart CC
    Cancer; 1996 May; 77(9):1844-9. PubMed ID: 8646683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ductal carcinoma in situ in dynamic MR-mammography at 1.5 T].
    Fischer U; Westerhof JP; Brinck U; Korabiowska M; Schauer A; Grabbe E
    Rofo; 1996 Apr; 164(4):290-4. PubMed ID: 8645861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feature extraction and classification of dynamic contrast-enhanced T2*-weighted breast image data.
    Torheim G; Godtliebsen F; Axelson D; Kvistad KA; Haraldseth O; Rinck PA
    IEEE Trans Med Imaging; 2001 Dec; 20(12):1293-301. PubMed ID: 11811829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography.
    Hoffmann U; Brix G; Knopp MV; Hess T; Lorenz WJ
    Magn Reson Med; 1995 Apr; 33(4):506-14. PubMed ID: 7776881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
    Kim JS; Lee SM; Cha ES
    Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computed model of gadolinium enhanced MRI of breast disease.
    Kenney PJ; Sobol WT; Smith JK; Morgan DE
    Eur J Radiol; 1997 Feb; 24(2):109-19. PubMed ID: 9097052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Morphology and contrast enhancement of ductal carcinoma in situ in dynamic 1.0 T MR mammography].
    Sittek H; Kessler M; Heuck AF; Bredl T; Perlet C; Künzer I; Lebeau A; Untch M; Reiser M
    Rofo; 1997 Sep; 167(3):247-51. PubMed ID: 9376552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of peripheral enhancement in breast masses: correlation of findings on contrast medium enhanced MRI with histologic features and tumor angiogenesis.
    Buadu LD; Murakami J; Murayama S; Hashiguchi N; Sakai S; Toyoshima S; Masuda K; Kuroki S; Ohno S
    J Comput Assist Tomogr; 1997; 21(3):421-30. PubMed ID: 9135652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast disease: dynamic spiral MR imaging.
    Daniel BL; Yen YF; Glover GH; Ikeda DM; Birdwell RL; Sawyer-Glover AM; Black JW; Plevritis SK; Jeffrey SS; Herfkens RJ
    Radiology; 1998 Nov; 209(2):499-509. PubMed ID: 9807580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.